(HealthDay)—For patients with hepatitis C virus (HCV) infection and biopsy-proven cirrhosis, sustained viral response (SVR) is associated with a reduction in critical events, both liver and non-liver related, according ...
Jan 4, 2017
0
0
Newcastle scientists and medics have developed a promising new test to identify patients with a rare liver disease who will not respond to standard treatment, allowing earlier intervention with alternatives.
Dec 2, 2016
0
0
(HealthDay)—Timely administration of antibiotics is associated with a reduction in mortality among patients with cirrhosis and upper gastrointestinal bleeding (UGIB), according to a study published in the November issue ...
Oct 31, 2016
0
0
Chronic liver disease (CLD) and cirrhosis are serious liver conditions but little is known about how they affect ethnic minority populations in the United States. When researchers examined CLD and cirrhosis among different ...
Jul 19, 2016
0
0
Cirrhosis related ascites is a common and complex medical condition associated with increased morbidity, mortality, healthcare utilisation, and reduced quality of life. It is estimated that up to 0.5 per cent of the general ...
Apr 29, 2016
0
2
A new study by researchers at Baylor College of Medicine found that treatment and cure of chronic hepatitis C reduce the risk of hepatocellular carcinoma (HCC), especially if given early, before cirrhosis develops, and while ...
Apr 25, 2016
0
13
(HealthDay)—For patients with Child-Pugh B and C, propranolol use is associated with increased mortality, according to a letter to the editor published online March 26 in Hepatology.
Apr 10, 2016
0
10
(HealthDay)—Statin use is associated with decreased risk of cirrhosis decompensation and death in patients with hepatitis C virus (HCV)-related compensated cirrhosis, according to research published in the February issue ...
Feb 10, 2016
0
0
(HealthDay)—For patients admitted with diagnoses of cirrhosis and ascites, paracentesis is associated with decreased in-hospital mortality but is underutilized, according to a study published online Dec. 8 in the Journal ...
Dec 11, 2015
0
0
A study by IRB Barcelona and IDIBAPS reveals a therapeutic target to prevent the development of the many abnormal blood vessels that cause gastrointestinal bleeding—the main complication in cirrhosis.
Dec 11, 2015
0
13
